Skip to the main content.


KBI Biopharma, Inc. Releases Inaugural FIH Manufacturing Batch at Integrated Switzerland Facility Five Months After Opening

Milestone affirms KBI and Selexis SA’s Geneva cGMP site is operational and running successfully. GENEVA, March 21, 2023 – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced that late in 2022, it successfully released its...

Read More

KBI Biopharma Announced as 2023 ISPE Facility of the Year Submission Finalist

KBI Biopharma is thrilled to announce that Patriot Park has been named a finalist in the 2023 ISPE Facility of the Year Awards (FOYA) in two...

Read More

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

Following the recent Sudan ebolavirus outbreak in Uganda, KBI is providing emergency support through global production efforts. DURHAM, NC (January...

Read More

KBI Biopharma, Inc. Secures Swissmedic Regulatory Establishment License for State-of-the-Art Mammalian Cell Manufacturing Facility in Geneva

Major regulatory milestone demonstrates compliance with stringent standards for cGMP drug substance manufacturing. GENEVA, December 20, 2022– KBI...

Read More

A Look Back at 2022

What a year 2022 turned out to be! It was a year of growth and expansion, from the launch of our new KBI commercial manufacturing facility in...

Read More

Leuven Lives up to KBI's High Quality Expectations

The KBI Biopharma analytical facility in Leuven, Belgium, has received a successful inspection from Belgium’s regulatory authority, the Federal...

Read More

Tim Lowery Appointed Interim CEO of KBI and Selexis

Durham, North Carolina (November 09, 2022) -- KBI Biopharma & Selexis (“KBI”) today announced the appointment of JSR Life Sciences President Tim...

Read More

KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business Officer

KBI and Selexis welcome Abdelaziz Toumi, Ph.D., as Chief Business Officer. Toumi will lead Global Business Development for KBI and Selexis as well as...

Read More

KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland

The KBI and Selexis co-location will expand biopharmaceutical development and manufacturing capabilities to serve the global demand for novel...

Read More

KBI Biopharma SA and Selexis SA Expand in Europe by Opening an Integrated Biologics Manufacturing Facility in Geneva, Switzerland

GENEVA, June 14, 2022— KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, announced today that an expanded, fully-integrated...

Read More

Never Miss Another Update! 

Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.